Beta-blocker therapy and primary angioplasty: What is the controversy?

Journal of the American College of Cardiology

Volumn 43, Issue 10, 2004, Pages 1788-1790

  Faxon, David P ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL;

ANGIOPLASTY; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG RESEARCH; HEART EJECTION FRACTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE OXYGEN CONSUMPTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; NOTE; PHARMACEUTICAL CARE; PRIORITY JOURNAL;

EID: 2442497455     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.03.001     Document Type: Editorial

References (16)

1. Ryan T.J., Antman E.M., Brooks N.H., et al. 1999 update Acc/aha guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the american college of cardiology/american heart association task force on practice guidelines (committee on management of acute myocardial infarction). Circulation. 100:1999;1016-1030
2. Yusuf S., Peto R., Lewis J. Beta blockade during and after myocardial infarction An overview of the randomized trials. Prog Cariovasc Dis. 27:1985;335-371
3. Freemantle N., Cleland J., Young P., Mason J., Harrison J. Beta-blockade after myocardial infarction Systematic review and meta regression analysis. BMJ. 318:1999;1730-1737
4. Roberts R., Rogers W.J., Mueller H.S., et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis In Myocardial Infarction (TIMI) II-B study. Circulation. 83:1991;422-437
5. Dargie H., Colucci W., Ford I., et al. Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction The capricorn randomized trial. Lancet. 357:2001;1385-1390
6. Burwen D.R., Galusha D.H., Lewis J.M., et al. National and state trends in quality of care for acute myocardial infarction between 1994 to 1995 and 1998 to 1999; the Medicare health care quality improvement program. Arch Intern Med. 163:2003;1392-1393
7. Pancu D., Lee D.C. Beta-blocker use in the emergency department in patients with acute myocardial infarction undergoing primary angioplasty. J Emerg Med. 24:2003;379-382
8. Kernis SJ, Harjai KJ, Stone GW, et al. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty? J Am Coll Cardiol 2004;43:1773-9
9. Halkin A, Grines CL, Cox DA, et al. Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction. J Am Coll Cardiol 2004;43:1780-7
10. Mehta RH, Harjai KJ, Grines L. Sustained ventricular tachycardia or fibrillation in cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors and outcomes. J Am Coll Cardiol 2004;43:1765-72
11. Harjai K.J., Stone G.W., Boura J., et al. Effects of prior beta-blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction. Am J Cardiol. 91:2003;655-660
12. Nidorf S.M., Parsons R.W., Thompson P.L., Jarozik K.D., Hobbs M.S. Reduced risk of death at 28 days in patients taking a beta-blocker before admission to hospital with myocardial infarction. BMJ. 300:1990;71-74
13. Sharma S.K., Annapoorna K., Marmur J., Fuster V. Cardioprotective effect of prior beta-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention. Circulation. 102:2000;166-172
14. Wang F.W., Osman A., Javier O., et al. Distal myocardial protection during percutaneous coronary intervention with an intracoronary beta-blocker. Circulation. 107:2003;2914-2919
15. Ellis S.G., Brener S.J., Lincoff M., et al. Beta blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise. Circulation. 104:2001;2685-2688
16. Chan A.W., Quinn M.J., Bhatt D.L., et al. Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention. J Am Coll Cardiol. 40:2002;669-675